Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  Zamarrón, Carlos ^a   Valdés Cuadrado, Luis ^a   Álvarez Sala, Rodolfo ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GHRELIN; LEPTIN; RESISTIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; HUMAN; HYPERCOAGULABILITY; HYPOXEMIA; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; REOXYGENATION; SLEEP DISORDERED BREATHING; SNORING; VIBRATION;

EID: 84880274680     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/521087     Document Type: Article

References (221)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S., The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine 1993 328 17 1230 1235 2-s2.0-0027462562 10.1056/NEJM199304293281704 (Pubitemid 23115702)
2. Remmers J. E., DeGroot W. J., Sauerland E. K., Anch A. M., Pathogenesis of upper airway occlusion during sleep. Journal of Applied Physiology Respiratory Environmental and Exercise Physiology 1978 44 6 931 938 2-s2.0-0018236108 (Pubitemid 9158239)
3. Anstead M., Phillips B., The spectrum of sleep-disordered breathing. Respiratory Care Clinics of North America 1999 5 3 363 377 2-s2.0-0033191048
4. Lugaresi E., Plazzi G., Heavy snorer disease: from snoring to the sleep apnea syndrome-an overview. Respiration 1997 64 1 11 21 2-s2.0-0030853776 (Pubitemid 27384655)
5. Guilleminault C., Stoohs R., Shiomi T., Kushida C., Schnittger I., Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension. Chest 1996 109 4 901 908 2-s2.0-0029863081 (Pubitemid 26113628)
6. Berger K. I., Ayappa I., Chatr-Amontri B., Marfatia A., Sorkin I. B., Rapoport D. M., Goldring R. M., Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001 120 4 1231 1238 2-s2.0-0034786161 10.1378/chest.120.4.1231 (Pubitemid 32960099)
7. Gastaut H., Tassinari C. A., Duron B., Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome. Revue Neurologique 1965 112 6 568 579 2-s2.0-0013784209
8. Marin J. M., Carrizo S. J., Vicente E., Agusti A. G. N., Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet 2005 365 9464 1046 1053 2-s2.0-15244344823 10.1016/S0140-6736(05)71141-7 (Pubitemid 40386782)
9. Terán-Santos J., Jiménez-Gómez A., Cordero-Guevara J., The association between sleep apnea and the risk of traffic accidents. The New England Journal of Medicine 1999 340 11 847 851 2-s2.0-0344820724 10.1056/NEJM199903183401104 (Pubitemid 29142628)
10. Chaouat A., Weitzenblum E., Krieger J., Ifoundza T., Oswald M., Kessler R., Association of chronic obstructive pulmonary disease and sleep apnea syndrome. The American Journal of Respiratory and Critical Care Medicine 1995 151 1 82 86 2-s2.0-0028868266
11. Oldenburg O., Lamp B., Faber L., Teschler H., Horstkotte D., Töpfer V., Sleep-disordered breathing in patients with symptomatic heart failure. A contemporary study of prevalence in and characteristics of 700 patients. European Journal of Heart Failure 2007 9 3 251 257 2-s2.0-33847372988 10.1016/j.ejheart.2006.08.003 (Pubitemid 46335886)
12. Pichel F., Zamarrón C., Magán F., del Campo F., Alvarez-Sala R., Rodríguez Suarez J. R., Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment. Respiratory Medicine 2004 98 10 968 976 2-s2.0-11144254548 10.1016/j.rmed.2004.03.009 (Pubitemid 40029128)
13. Coughlin S. R., Mawdsley L., Mugarza J. A., Calverley P. M. A., Wilding J. P. H., Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. European Heart Journal 2004 25 9 735 741 2-s2.0-2442580978 10.1016/j.ehj.2004.02.021 (Pubitemid 38647933)
14. Durán J., Esnaola S., Rubio R., Iztueta Á., Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. The American Journal of Respiratory and Critical Care Medicine 2001 163 3, part 1 685 689 2-s2.0-0035077341 (Pubitemid 32230829)
15. Udwadia Z. F., Doshi A. V., Lonkar S. G., Singh C. I., Prevalence of sleep-disordered breathing and sleep apnea in middle-aged urban Indian men. The American Journal of Respiratory and Critical Care Medicine 2004 169 2 168 173 2-s2.0-1642452929 10.1164/rccm.200302-265OC (Pubitemid 38114530)
16. Sharma S. K., Kumpawat S., Banga A., Goel A., Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest 2006 130 1 149 156 2-s2.0-33746344985 10.1378/chest.130.1.149 (Pubitemid 44116853)
17. Pływaczewski R., Bednarek M., Jonczak L., Zieliński J., Sleep-disordered breathing in a middle-aged and older Polish urban population. Journal of Sleep Research 2008 17 1 73 81 2-s2.0-39049156457 10.1111/j.1365-2869.2008.00632.x (Pubitemid 351239361)
18. Ancoli-Israel S., Coy T., Are breathing disturbances in elderly equivalent to sleep apnea syndrome? Sleep 1994 17 1 77 83 2-s2.0-0028323645 (Pubitemid 24103644)
19. Young T., Sleep-disordered breathing in older adults: is it a condition distinct from that in middle-aged adults? Sleep 1996 19 7 529 530 2-s2.0-0030229145
20. Fung M. M., Peters K., Redline S., Ziegler M. G., Ancoli-Israel S., Barrett-Connor E., Stone K. L., Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension 2011 58 4 596 603 2-s2.0-80053576969 10.1161/HYPERTENSIONAHA.111.174409
21. Bekci T. T., Kayrak M., Kiyici A., Maden E., Ari H., Kaya Z., Teke T., Akilli H., The association among lipoprotein-associated phospholipase A2 levels, total antioxidant capacity and arousal in male patients with OSA. International Journal of Medical Sciences 2011 8 5 369 376 2-s2.0-84860409411
22. Follenius M., Krieger J., Krauth M. O., Sforza F., Brandenberger G., Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991 14 3 211 217 2-s2.0-0025739442
23. Møller D. S., Lind P., Strunge B., Pedersen E. B., Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. The American Journal of Hypertension 2003 16 4 274 280 2-s2.0-0037381920 10.1016/S0895-7061(02)03267-3 (Pubitemid 36384754)
24. Patel S. R., Zhu X., Storfer-Isser A., Mehra R., Jenny N. S., Tracy R., Redline S., Sleep duration and biomarkers of inflammation. Sleep 2009 32 2 200 204 2-s2.0-62549120766
25. Gozal D., Serpero L. D., Kheirandish-Gozal L., Capdevila O. S., Khalyfa A., Tauman R., Sleep measures and morning plasma TNF-α levels in children with sleep-disordered breathing. Sleep 2010 33 3 319 325 2-s2.0-77649240382
26. Somers V. K., Mark A. L., Abboud F. M., Sympathetic activation by hypoxia and hypercapnia-implications for sleep apnea. Clinical and Experimental Hypertension A 1988 10 1 413 422 2-s2.0-0024217815 (Pubitemid 19078441)
27. Imadojemu V. A., Mawji Z., Kunselman A., Gray K. S., Hogeman C. S., Leuenberger U. A., Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007 131 5 1406 1413 2-s2.0-34248578612 10.1378/chest.06-2580 (Pubitemid 46762346)
28. Prabhakar N. R., Fields R. D., Baker T., Fletcher E. C., Intermittent hypoxia: cell to system. The American Journal of Physiology 2001 281 3 L524 L528 2-s2.0-0034835692
29. Somers V. K., Dyken M. E., Clary M. P., Abboud F. M., Sympathetic neural mechanisms in obstructive sleep apnea. Journal of Clinical Investigation 1995 96 4 1897 1904 2-s2.0-0028841211
30. Tamisier R., Pépin J. L., Rémy J., Baguet J. P., Taylor J. A., Weiss J. W., Lévy P., 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. European Respiratory Journal 2011 37 1 119 128 2-s2.0-79251540222 10.1183/09031936. 00204209
31. Von Känel R., Dimsdale J. E., Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003 124 5 1956 1967 2-s2.0-10744229839 10.1378/chest.124.5.1956 (Pubitemid 37433597)
32. Maser R. E., Lenhard M. J., Rizzo A. A., Vasile A. A., Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest 2008 133 1 86 91 2-s2.0-38349019594 10.1378/chest.07-1580
33. Marrone O., Salvaggio A., Bue A. L., Bonanno A., Riccobono L., Insalaco G., Bonsignore M. R., Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clinical and Experimental Hypertension 2011 33 6 373 380 2-s2.0-80053287705 10.3109/10641963.2010.531853
34. Robinson G. V., Pepperell J. C. T., Segal H. C., Davies R. J. O., Stradling J. R., Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004 59 9 777 782 2-s2.0-4544314483 10.1136/thx.2003.018739 (Pubitemid 39215375)
35. Schulz R., Mahmoudi S., Hattar K., Sibelius U. L. F., Olschewski H., Mayer K., Seeger W., Grimminger F., Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. The American Journal of Respiratory and Critical Care Medicine 2000 162 2, part 1 566 570 2-s2.0-0033845075 (Pubitemid 30647201)
36. Lavie L., Vishnevsky A., Lavie P., Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004 27 1 123 128 2-s2.0-2442674412 (Pubitemid 43906323)
37. Carpagnano G. E., Kharitonov S. A., Resta O., Foschino-Barbaro M. P., Gramiccioni E., Barnes P. J., 8-isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003 124 4 1386 1392 2-s2.0-0142042362 10.1378/chest.124.4.1386 (Pubitemid 37290049)
38. Alonso-Fernández A., García-Río F., Arias M. A., Hernanz Á., de la Peña M., Piérola J., Barceló A., López-Collazo E., Agustí A., Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009 64 7 581 586 2-s2.0-67650245608 10.1136/thx.2008.100537
39. Celec P., Hodosy J., Behuliak M., Pálffy R., Gardlík R., Halčák L., Mucska I., Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep and Breathing 2012 16 2 393 398 2-s2.0-79952832868 10.1007/s11325-011- 0510-4
40. Malakasioti G., Alexopoulos E., Befani C., Tanou K., Varlami V., Ziogas D., Liakos P., Gourgoulianis K., Kaditis A. G., Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep and Breathing 2012 16 3 703 708 2-s2.0-79960872485 10.1007/s11325-011- 0560-7
41. Teramoto S., Kume H., Yamamoto H., Ishii T., Miyashita A., Matsuse T., Akishita M., Toba K., Ouchi Y., Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Internal Medicine 2003 42 8 681 685 2-s2.0-0041472355 (Pubitemid 37021199)
42. Marrone O., Salvaggio A., Gioia M., Bonanno A., Profita M., Riccobono L., Zito A., Insalaco G., Bonsignore M. R., Reticulocytes in untreated obstructive sleep apnoea. Monaldi Archives for Chest Disease 2008 69 3 107 113 2-s2.0-57849083530
43. Belaidi E., Joyeux-Faure M., Ribuot C., Launois S. H., Levy P., Godin-Ribuot D., Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. Journal of the American College of Cardiology 2009 53 15 1309 1317 2-s2.0-63549129273 10.1016/j.jacc.2008.12.050
44. Dyugovskaya L., Lavie P., Lavie L., Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. The American Journal of Respiratory and Critical Care Medicine 2002 165 7 934 939 2-s2.0-0036528981 (Pubitemid 34774660)
45. Park A., Nagase H., Kumar S. V., Suzuki Y. J., Effects of intermittent hypoxia on the heart. Antioxidants and Redox Signaling 2007 9 6 723 729 2-s2.0-34249062366 10.1089/ars.2007.1460 (Pubitemid 46799104)
46. Barceló A., Barbé F., de la Peña M., Vila M., Pérez G., Piérola J., Durán J., Agustí A. G., Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. European Respiratory Journal 2006 27 4 756 760 10.1183/09031936.06.00067605 (Pubitemid 44914199)
47. Grebe M., Eisele H. J., Weissmann N., Schaefer C., Tillmanns H., Seeger W., Schulz R., Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2006 173 8 897 901 2-s2.0-33645514937 10.1164/rccm.200508-1223OC
48. Lattimore J. L., Wilcox I., Nakhla S., Langenfeld M., Jessup W., Celermajer D. S., Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis 2005 179 2 255 259 2-s2.0-14944368925 10.1016/j.atherosclerosis.2004.11.010 (Pubitemid 40364618)
49. Wysocka E., Cofta S., Cymerys M., Gozdzik J., Torlinski L., Batura-Gabryel H., The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. Journal of Physiology and Pharmacology 2008 59 supplement 6 761 769 2-s2.0-64549109302
50. Jelic S., Lederer D. J., Adams T., Padeletti M., Colombo P. C., Factor P. H., Le Jemtel T. H., Vascular inflammation in obesity and sleep apnea. Circulation 2010 121 8 1014 1021 2-s2.0-77649257683 10.1161/CIRCULATIONAHA.109. 900357
51. Alzoghaibi M. A., BaHammam A. S., The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep and Breathing 2012 16 2 499 504 2-s2.0-79955774526 10.1007/s11325-011-0531-z
52. Nair D., Dayyat E. A., Zhang S. X., Wang Y., Gozal D., Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea. PLoS ONE 2011 6 5 2-s2.0-79956347138 10.1371/journal.pone.0019847 e19847
53. Devouassoux G., Lévy P., Rossini E., Pin I., Fior-Gozlan M., Henry M., Seigneurin D., Pépin J., Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. Journal of Allergy and Clinical Immunology 2007 119 3 597 603 2-s2.0-33847314540 10.1016/j.jaci.2006.11.638
54. Carpagnano G. E., Spanevello A., Sabato R., Depalo A., Palladino G. P., Bergantino L., Barbaro M. P. F., Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Translational Research 2010 155 1 35 43 2-s2.0-71249089214 10.1016/j.trsl.2009.09.004
55. Cofta S., Wysocka E., Dziegielewska-Gesiak S., Michalak S., Piorunek T., Batura-Gabryel H., Torlinski L., Plasma selectins in patients with obstructive sleep apnea. Advances in Experimental Medicine and Biology 2013 756 113 119 10.1007/978-94-007-4549-0-15
56. El-Solh A. A., Mador M. J., Sikka P., Dhillon R. S., Amsterdam D., Grant B. J. B., Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002 121 5 1541 1547 2-s2.0-0036247736 10.1378/chest.121.5.1541 (Pubitemid 34499668)
57. Zamarrón-Sanz C., Ricoy-Galbaldon J., Gude-Sampedro F., Riveiro-Riveiro A., Plasma levels of vascular endothelial markers in obstructive sleep apnea. Archives of Medical Research 2006 37 4 552 555 2-s2.0-33646036363 10.1016/j.arcmed.2005.10.011
58. Dyugovskaya L., Polyakov A., Lavie P., Lavie L., Delayed neutrophil apoptosis in patients with sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2008 177 5 544 554 2-s2.0-40649097290 10.1164/rccm.200705-675OC (Pubitemid 351442194)
59. Imagawa S., Yamaguchi Y., Ogawa K., Obara N., Suzuki N., Yamamoto M., Nagasawa T., Interleukin-6 and tumor necrosis factor-α in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 2004 71 1 24 29 2-s2.0-1242306602 10.1159/000075645 (Pubitemid 38223762)
60. de la Peña Bravo M., Serpero L. D., Barceló A., Barbé F., Agustí A., Gozal D., Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep and Breathing 2007 11 3 177 185 2-s2.0-34548162405 10.1007/s11325-007-0100-7 (Pubitemid 47307847)
61. Steiropoulos P., Kotsianidis I., Nena E., Tsara V., Gounari E., Hatzizisi O., Kyriazis G., Christaki P., Froudarakis M., Bouros D., Long-term effect of continuous positive airway pressure therapy on infammation markers of patients with obstructive sleep apnea syndrome. Sleep 2009 32 4 537 543 2-s2.0-65249129771
62. Arias M. A., García-Río F., Alonso-Fernández A., Hernanz A., Hidalgo R., Martínez-Mateo V., Bartolomé S., Rodríguez-Padial L., CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea. European Respiratory Journal 2008 32 4 1009 1015 2-s2.0-58849088063 10.1183/09031936. 00007008
63. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
64. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005 352 16 1685 1695 2-s2.0-17644412023 10.1056/NEJMra043430 (Pubitemid 40530235)
65. Delanghe J. R., Langlois M. R., de Bacquer D., Mak R., Capel P., van Renterghem L., de Backer G., Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 2002 160 2 471 476 2-s2.0-0036182631 10.1016/S0021-9150(01)00607-4 (Pubitemid 34159343)
66. Svatikova A., Wolk R., Shamsuzzaman A. S., Kara T., Olson E. J., Somers V. K., Serum amyloid a in obstructive sleep apnea. Circulation 2003 108 12 1451 1454 2-s2.0-0141727714 10.1161/01.CIR.0000089091.09527.B8 (Pubitemid 37176450)
67. Kuramoto E., Kinami S., Ishida Y., Shiotani H., Nishimura Y., Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome. International Journal of Cardiology 2009 135 3 338 345 2-s2.0-67349183251 10.1016/j.ijcard.2008.03.078
68. Rutter M. K., Meigs J. B., Sullivan L. M., D'Agostino R. B. Sr., Wilson P. W. F., C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 2004 110 4 380 385 2-s2.0-3242662149 10.1161/01.CIR.0000136581.59584.0E (Pubitemid 38993845)
69. Shamsuzzaman A. S. M., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., Somers V. K., Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002 105 21 2462 2464 2-s2.0-0037188605 10.1161/01.CIR.0000018948.95175.03 (Pubitemid 34568964)
70. Kokturk O., Ciftci T. U., Mollarecep E., Ciftci B., Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. International Heart Journal 2005 46 5 801 809 2-s2.0-33644876188 10.1536/ihj.46.801
71. Taheri S., Austin D., Lin L., Nieto F. J., Young T., Mignot E., Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007 30 8 991 996 2-s2.0-34547690717 (Pubitemid 47221899)
72. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., Hirano T., Adachi M., Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003 107 8 1129 1134 2-s2.0-0037418181 10.1161/01.CIR.0000052627.99976.18 (Pubitemid 36297204)
73. Schiza S. E., Mermigkis C., Panagiotis P., Bouloukaki I., Kallergis E., Tzanakis N., Tzortzaki E., Vlachaki E., Siafakas N. M., C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. European Journal of Clinical Investigation 2010 40 11 968 975 2-s2.0-78649417624 10.1111/j.1365-2362.2010.02348.x
74. Ryan S., Taylor C. T., McNicholas W. T., Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005 112 17 2660 2667 2-s2.0-27444448072 10.1161/CIRCULATIONAHA.105.556746 (Pubitemid 41532603)
75. Yu H. J., Lin B. R., Lee H. S., Shun C. T., Yang C. C., Lai T. Y., Chien C. T., Hsu S. M., Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver. The American Journal of Physiology 2005 288 5 F1005 F1014 2-s2.0-17644398158 10.1152/ajprenal.00223.2004 (Pubitemid 40569767)
76. Guzik T. J., Hoch N. E., Brown K. A., McCann L. A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D. G., Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. Journal of Experimental Medicine 2007 204 10 2449 2460 2-s2.0-34948825774 10.1084/jem.20070657 (Pubitemid 47529329)
77. Kasai T., Inoue K., Kumagai T., Kato M., Kawana F., Sagara M., Ishiwata S., Ohno M., Yamaguchi T., Momomura S., Narui K., Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. The American Journal of Hypertension 2011 24 4 401 407 2-s2.0-79952964570 10.1038/ajh.2010.248
78. Arnaud C., Beguin P. C., Lantuejoul S., Pepin J., Guillermet C., Pelli G., Burger F., Buatois V., Ribuot C., Baguet J., Mach F., Levy P., Dematteis M., The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. The American Journal of Respiratory and Critical Care Medicine 2011 184 6 724 731 2-s2.0-80052582006 10.1164/rccm.201012-2033OC
79. Carreras A., Almendros I., Montserrat J. M., Navajas D., Farré R., Mesenchymal stem cells reduce inflammation in a rat model of obstructive sleep apnea. Respiratory Physiology and Neurobiology 2010 172 3 210 212 2-s2.0-77954385219 10.1016/j.resp.2010.05.020
80. Querido J. S., Sheel A. W., Cheema R., van Eeden S., Mulgrew A. T., Ayas N. T., Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans. Sleep and Breathing 2012 16 3 657 662 2-s2.0-79959956005 10.1007/s11325-011-0555-4
81. Zouaoui Boudjeltia K., Guillaume M., Henuzet C., Delrée P., Cauchie P., Remacle C., Ducobu J., Vanhaeverbeek M., Brohée D., Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count. European Journal of Internal Medicine 2006 17 2 102 108 2-s2.0-33144464451 10.1016/j.ejim.2005.11.002 (Pubitemid 43265859)
82. Bratseth V., Pettersen A. A., Opstad T. B., Arnesen H., Seljeflot I., Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment. Thrombosis Journal 2012 10 article 12 10.1186/1477-9560-10-12
83. Peled N., Kassirer M., Kramer M. R., Rogowski O., Shlomi D., Fox B., Berliner A. S., Shitrit D., Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thrombosis Research 2008 121 5 631 636 2-s2.0-39749152858 10.1016/j.thromres.2007.07.010 (Pubitemid 351305295)
84. Othman M., Gordon S. P., Iscoe S., Repeated inspiratory occlusions in anesthetized rats acutely increase blood coagulability as assessed by thromboelastography. Respiratory Physiology and Neurobiology 2010 171 1 61 66 2-s2.0-77949567630 10.1016/j.resp.2010.01.010
85. Reinhart W. H., Oswald J., Walter R., Kuhn M., Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clinical Hemorheology and Microcirculation 2002 27 3-4 201 207 2-s2.0-0036974515 (Pubitemid 36160263)
86. von Känel R., Loredo J. S., Powell F. L., Adler K. A., Dimsdale J. E., Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clinical Hemorheology and Microcirculation 2005 33 4 369 377 2-s2.0-28644452205 (Pubitemid 41750562)
87. Akinnusi M. E., Paasch L. L., Szarpa K. R., Wallace P. K., El Solh A. A., Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 2009 77 1 25 31 2-s2.0-58249103065 10.1159/000158488
88. von Känel R., Loredo J. S., Ancoli-Israel S., Dimsdale J. E., Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep and Breathing 2006 10 3 139 146 2-s2.0-33748333111 10.1007/s11325-006-0060-3 (Pubitemid 44322495)
89. Zamarrón C., Ricoy J., Riveiro A., Gude F., Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 2008 186 3 151 156 2-s2.0-44549083893 10.1007/s00408-008-9076-8
90. Shitrit D., Peled N., Shitrit A. B., Meidan S., Bendayan D., Sahar G., Kramer M. R., An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thrombosis and Haemostasis 2005 94 3 544 547 2-s2.0-24944511641 10.1160/TH05-02-0103 (Pubitemid 41300850)
91. von Känel K. R., Natarajan L., Ancoli-Israel S., Mills P. J., Wolfson T., Gamst A. C., Loredo J. S., Dimsdale J. E., Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Medicine 2013 14 1 58 65 10.1016/j.sleep.2012.07. 009
92. von Känel R., Loredo J. S., Ancoli-Israel S., Mills P. J., Natarajan L., Dimsdale J. E., Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 2007 131 3 733 739 2-s2.0-33947375205 10.1378/chest.06-2006 (Pubitemid 46446864)
93. Cleland S. J., Sattar N., Petrie J. R., Forouhi N. G., Elliott H. L., Connell J. M. C., Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clinical Science 2000 98 5 531 535 2-s2.0-0034016962 (Pubitemid 30261001)
94. Hadi H. A. R., Al Suwaidi J. A., Endothelial dysfunction in diabetes mellitus. Vascular Health and Risk Management 2007 3 6 853 876 2-s2.0-38149142583
95. Halcox J. P. J., Donald A. E., Ellins E., Witte D. R., Shipley M. J., Brunner E. J., Marmot M. G., Deanfield J. E., Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009 119 7 1005 1012 2-s2.0-61849099312 10.1161/CIRCULATIONAHA.108.765701
96. Anderson T. J., Uehata A., Gerhard M. D., Meredith I. T., Knab S., Delagrange D., Lieberman E. H., Ganz P., Creager M. A., Yeung A. C., Selwyn A. P., Close relation of endothelial function in the human coronary and peripheral circulations. Journal of the American College of Cardiology 1995 26 5 1235 1241 2-s2.0-0028784709 10.1016/0735-1097(95)00327-4
97. Oyama J., Yamamoto H., Maeda T., Ito A., Node K., Makino N., Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clinical Cardiology 2012 35 4 231 236 2-s2.0-84859766047 10.1002/clc.21010
98. Ip M. S. M., Tse H., Lam B., Tsang K. W. T., Lam W., Endothelial function in obstructive sleep apnea and response to treatment. The American Journal of Respiratory and Critical Care Medicine 2004 169 3 348 353 2-s2.0-1642578214 (Pubitemid 38134813)
99. Trzepizur W., Gagnadoux F., Abraham P., Rousseau P., Meslier N., Saumet J., Racineux J., Microvascular endothelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Medicine 2009 10 7 746 752 2-s2.0-67650616576 10.1016/j.sleep.2008.06.013
100. Haight J. S. J., Djupesland P. G., Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep and Breathing 2003 7 2 53 62 2-s2.0-0037622696
101. Nieto F. J., Herrington D. M., Redline S., Benjamin E. J., Robbins J. A., Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. The American Journal of Respiratory and Critical Care Medicine 2004 169 3 354 360 2-s2.0-1642537652 (Pubitemid 38134814)
102. Kohler M., Craig S., Nicoll D., Leeson P., Davies R. J. O., Stradling J. R., Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2008 178 9 984 988 2-s2.0-55549091434 10.1164/rccm.200805-717OC
103. de la Peña M., Barceló A., Barbe F., Piérola J., Pons J., Rimbau E., Ayllón O., Agustí A. G. N., Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 2008 76 1 28 32 2-s2.0-46249087312 10.1159/000109643 (Pubitemid 351914136)
104. Kohler M., Stoewhas A., Ayers L., Senn O., Bloch K. E., Russi E. W., Stradling J. R., Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. The American Journal of Respiratory and Critical Care Medicine 2011 184 10 1192 1199 2-s2.0-81455128860 10.1164/rccm.201106-0964OC
105. Ciccone M. M., Favale S., Scicchitano P., Mangini F., Mitacchione G., Gadaleta F., Longo D., Iacoviello M., Forleo C., Quistelli G., Taddei S., Resta O., Carratù P., Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. International Journal of Cardiology 2012 158 3 383 386 2-s2.0-79951854855 10.1016/j.ijcard.2011.01.065
106. Kanagy N. L., Walker B. R., Nelin L. D., Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001 37 2 511 515 2-s2.0-0035092612 (Pubitemid 32199020)
107. Phillips B. G., Narkiewicz K., Pesek C. A., Haynes W. G., Dyken M. E., Somers V. K., Effects of obstructive sleep apnea on endothelin-1 and blood pressure. Journal of Hypertension 1999 17 1 61 66 2-s2.0-0032976443 (Pubitemid 29086189)
108. Saarelainen S., Hasan J., Circulating endothelin-1 and obstructive sleep apnoea. European Respiratory Journal 2000 16 4 794 795 2-s2.0-0033772973
109. Grimpen F., Kanne P., Schulz E., Hagenah G., Hasenfuß G., Andreas S., Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. European Respiratory Journal 2000 15 2 320 325 2-s2.0-0033950071 10.1034/j.1399-3003.2000.15b17.x (Pubitemid 30085960)
110. Gjørup P. H., Sadauskiene L., Wessels J., Nyvad O., Strunge B., Pedersen E. B., Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. The American Journal of Hypertension 2007 20 1 44 52 2-s2.0-33845805818 10.1016/j.amjhyper.2006.05.021 (Pubitemid 46014056)
111. Rossi G. P., Pitter G., Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies? Annals of the New York Academy of Sciences 2006 1069 34 50 2-s2.0-33745632032 10.1196/annals.1351.004 (Pubitemid 43989849)
112. Pohl U., Busse R., Differential vascular sensitivity to luminally and adventitially applied endothelin-1. Journal of Cardiovascular Pharmacology 1989 13 supplement 5 S188 S190 2-s2.0-0024544250 (Pubitemid 19119243)
113. Kheirandish-Gozal L., Bhattacharjee R., Kim J., Clair H. B., Gozal D., Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2010 182 1 92 97 2-s2.0-77955867907 10.1164/rccm.200912-1845OC
114. Berger S., Lavie L., Endothelial progenitor cells in cardiovascular disease and hypoxia-potential implications to obstructive sleep apnea. Translational Research 2011 158 1 1 13 2-s2.0-79959756428 10.1016/j.trsl.2010. 12.008
115. Patt B. T., Jarjoura D., Haddad D. N., Sen C. K., Roy S., Flavahan N. A., Khayat R. N., Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2010 182 12 1540 1545 2-s2.0-78650213191 10.1164/rccm.201002-0162OC
116. Büchner N. J., Quack I., Woznowski M., Stähle C., Wenzel U., Rump L. C., Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration 2011 82 5 409 417 2-s2.0-80054752302 10.1159/000323266
117. Lee S. A., Amis T. C., Byth K., Larcos G., Kairaitis K., Robinson T. D., Wheatley J. R., Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 2008 31 9 1207 1213 2-s2.0-51349147538
118. Amatoury J., Howitt L., Wheatley J. R., Avolio A. P., Amis T. C., Snoring-related energy transmission to the carotid artery in rabbits. Journal of Applied Physiology 2006 100 5 1547 1553 2-s2.0-33646405437 10.1152/ japplphysiol.01439.2005
119. Howitt L., Kairaitis K., Kirkness J. P., Garlick S. R., Wheatley J. R., Byth K., Amis T. C., Oscillatory pressure wave transmission from the upper airway to the carotid artery. Journal of Applied Physiology 2007 103 5 1622 1627 2-s2.0-35649025290 10.1152/japplphysiol.01413.2006 (Pubitemid 350033846)
120. Cho J., Witting P. K., Verma M., Wu B. J., Shanu A., Kairaitis K., Amis T. C., Wheatley J. R., Tissue vibration induces carotid artery endothelial dysfunction: a mechanism linking snoring and carotid atherosclerosis? Sleep 2011 34 6 751 757 2-s2.0-79957935981 10.5665/SLEEP.1042
121. Wolk R., Shamsuzzaman A. S. M., Somers V. K., Obesity, sleep apnea, and hypertension. Hypertension 2003 42 6 1067 1074 2-s2.0-0348109419 10.1161/01.HYP.0000101686.98973.A3 (Pubitemid 37549057)
122. Young T., Peppard P. E., Taheri S., Excess weight and sleep-disordered breathing. Journal of Applied Physiology 2005 99 4 1592 1599 2-s2.0-29544434090 10.1152/japplphysiol.00587.2005 (Pubitemid 43014371)
123. Schäfer H., Pauleit D., Sudhop T., Gouni-Berthold I., Ewig S., Berthold H. K., Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002 122 3 829 839 2-s2.0-0036384408 10.1378/chest.122.3.829
124. Canapari C. A., Hoppin A. G., Kinane T. B., Thomas B. J., Torriani M., Katz E. S., Relationship between sleep apnea, fat distribution, and insulin resistance in obese children. Journal of Clinical Sleep Medicine 2011 7 3 268 273 2-s2.0-79959294703 10.5664/JCSM.1068
125. Vgontzas A. N., Papanicolaou D. A., Bixler E. O., Hopper K., Lotsikas A., Lin H., Kales A., Chrousos G. P., Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. Journal of Clinical Endocrinology and Metabolism 2000 85 3 1151 1158 2-s2.0-0034455007 10.1210/jc.85.3.1151 (Pubitemid 32269364)
126. Nagaretani H., Nakamura T., Funahashi T., Kotani K., Miyanaga M., Tokunaga K., Takahashi M., Nishizawa H., Kishida K., Kuriyama H., Hotta K., Yamashita S., Matsuzawa Y., Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 2001 24 12 2127 2133 2-s2.0-0035650934 (Pubitemid 33716533)
127. Isono S., Obstructive sleep apnea of obese adults: pathophysiology and perioperative airway management. Anesthesiology 2009 110 4 908 921 2-s2.0-65349139435 10.1097/ALN.0b013e31819c74be
128. Schwartz A. R., Patil S. P., Laffan A. M., Polotsky V., Schneider H., Smith P. L., Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proceedings of the American Thoracic Society 2008 5 2 185 192 2-s2.0-39049102870 10.1513/pats.200708-137MG (Pubitemid 351237877)
129. Ronti T., Lupattelli G., Mannarino E., The endocrine function of adipose tissue: an update. Clinical Endocrinology 2006 64 4 355 365 2-s2.0-33644911756 10.1111/j.1365-2265.2006.02474.x
130. Proulx K., Richard D., Walker C., Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake. Endocrinology 2002 143 12 4683 4692 2-s2.0-0036892158 10.1210/en.2002-220593 (Pubitemid 35397610)
131. Phillips B. G., Kato M., Narkiewicz K., Choe I., Somers V. K., Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. The American Journal of Physiology 2000 279 1 H234 H237 2-s2.0-0033862686 (Pubitemid 30616665)
132. Tokuda F., Sando Y., Matsui H., Koike H., Yokoyama T., Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Internal Medicine 2008 47 21 1843 1849 2-s2.0-56349116660 10.2169/internalmedicine.47.1035
133. Ip M. S. M., Lam K. S. L., Ho C., Tsang K. W. T., Lam W., Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000 118 3 580 586 2-s2.0-0033801432
134. Sanner B. M., Kollhosser P., Buechner N., Zidek W., Tepel M., Influence of treatment on leptin levels in patients with obstructive sleep apnoea. European Respiratory Journal 2004 23 4 601 604 2-s2.0-1842481176 10.1183/09031936.04.00067804 (Pubitemid 38456004)
135. Patel S. R., Palmer L. J., Larkin E. K., Jenny N. S., White D. P., Redline S., Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 2004 27 2 235 239 2-s2.0-3242815509 (Pubitemid 44138831)
136. Tatsumi K., Kasahara J., Kurosu K., Tanabe N., Takiguchi Y., Kuriyama T., Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005 127 3 716 721 2-s2.0-15844403111 10.1378/chest.127.3.716 (Pubitemid 40775497)
137. Shimura R., Tatsumi K., Nakamura A., Kasahara Y., Tanabe N., Takiguchi Y., Kuriyama T., Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 2005 127 2 543 549 2-s2.0-13644267001 10.1378/chest.127.2.543 (Pubitemid 40229315)
138. Shimizu K., Nakamura T., Niimi A., Hattori N., Mishima M., Chin K., Nakamura T., Nohara R., Hosokawa R., Sasayama S., Masuzaki H., Ogawa Y., Nakao K., Ohi M., Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002 57 5 429 434 2-s2.0-0036261007 10.1136/thorax.57.5.429 (Pubitemid 34494154)
139. Çuhadarolu C., Utkusavaş A., Öztürk L., Salman S., Ece T., Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009 187 2 75 81 2-s2.0-67649101346 10.1007/s00408-008-9131-5
140. Snitker S., Pratley R. E., Nicolson M., Tataranni P. A., Ravussin E., Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obesity Research 1997 5 4 338 340 2-s2.0-0031179154 (Pubitemid 127702713)
141. Brooks B., Cistulli P. A., Borkman M., Ross G., McGhee S., Grunstein R. R., Sullivan C. E., Yue D. K., Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. Journal of Clinical Endocrinology and Metabolism 1994 79 6 1681 1685 2-s2.0-0028580628
142. Öztürk L., Ünal M., Tamer L., Çelikolu F., The association of the severity of obstructive sleep apnea with plasma leptin levels. Archives of Otolaryngology-Head and Neck Surgery 2003 129 5 538 540 2-s2.0-0038630630 10.1001/archotol.129.5.538 (Pubitemid 36576396)
143. Zirlik S., Hauck T., Fuchs F. S., Neurath M. F., Konturek P. C., Harsch I. A., Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Medical Science Monitor 2011 17 3 CR159 CR164 2-s2.0-84855495133
144. Al Lawati N., Mulgrew A., Cheema R., Vaneeden S., Butt A., Fleetham J., Ryan F., Ayas N., Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea. Sleep and Breathing 2009 13 4 391 395 2-s2.0-70350270371 10.1007/s11325-009-0259-1
145. Kapsimalis F., Varouchakis G., Manousaki A., Daskas S., Nikita D., Kryger M., Gourgoulianis K., Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008 186 4 209 217 2-s2.0-47549104119 10.1007/s00408-008-9082-x
146. Macrea M., Martin T., Zagrean L., Jia Z., Misra H., Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method. Sleep and Breathing 2013 17 1 105 110 10.1007/s11325-012-0656-8
147. Oh D. K., Ciaraldi T., Henry R. R., Adiponectin in health and disease. Diabetes, Obesity and Metabolism 2007 9 3 282 289 2-s2.0-33947663558 10.1111/j.1463-1326.2006.00610.x (Pubitemid 46502045)
148. Ouchi N., Walsh K., Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 2007 380 1-2 24 30 2-s2.0-33947627537 10.1016/j.cca.2007.01.026 (Pubitemid 46498041)
149. Zhang X. L., Yin K. S., Wang H., Su S., Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006 73 1 73 77 2-s2.0-33644515685 10.1159/000088690
150. Masserini B., Morpurgo P. S., Donadio F., Baldessari C., Beck-Peccoz P., Orsi E., Reduced levels of adiponectin in sleep apnea syndrome. Journal of Endocrinological Investigation 2006 29 8 700 705 2-s2.0-33751030217 (Pubitemid 44756174)
151. Vatansever E., Surmen-Gur E., Ursavas A., Karadag M., Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep and Breathing 2011 15 3 275 282 2-s2.0-80054929356 10.1007/s11325-010-0378-8
152. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., Paschke R., Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003 301 4 1045 1050 2-s2.0-0037459090 10.1016/S0006-291X(03) 00090-1 (Pubitemid 36279218)
153. McNicholas W. T., Bonsignore M. R., Sleep apnoea as an independent risk for cardiovascular disease: current evidence, basic mechanisms and research priorities. European Respiratory Journal 2007 29 1 156 178 2-s2.0-33846188093 10.1183/09031936.00027406 (Pubitemid 46092013)
154. Carneiro G., Togeiro S. M., Ribeiro-Filho F. F., Truksinas E., Ribeiro A. B., Zanella M. T., Tufik S., Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metabolic Syndrome and Related Disorders 2009 7 6 537 542 2-s2.0-70350348254 10.1089/met.2009.0019
155. de Lima A. M. J., Franco C. M. R., de Castro C. M. M. B., Bezerra A. D. A., Ataíde L. Jr., Halpern A., Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 2010 79 5 370 376 2-s2.0-77951298524 10.1159/000227800
156. Makino S., Handa H., Suzukawa K., Fujiwara M., Nakamura M., Muraoka S., Takasago I., Tanaka Y., Hashimoto K., Sugimoto T., Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clinical Endocrinology 2006 64 1 12 19 2-s2.0-33644963542 10.1111/j.1365-2265.2005.02407. x
157. Nakagawa Y., Kishida K., Kihara S., Yoshida R., Funahashi T., Shimomura I., Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue. Journal of Atherosclerosis and Thrombosis 2011 18 3 240 247 2-s2.0-79953294011
158. Jamaluddin M. S., Weakley S. M., Yao Q., Chen C., Resistin: functional roles and therapeutic considerations for cardiovascular disease. The British Journal of Pharmacology 2012 165 3 622 632 2-s2.0-84855646847 10.1111/j.1476-5381.2011.01369.x
159. Harsch I. A., Koebnick C., Wallaschofski H., Schahin S. P., Hahn E. G., Ficker J. H., Lohmann T., Konturek P. C., Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Medical Science Monitor 2004 10 9 CR510 CR515 2-s2.0-4644285153 (Pubitemid 39278559)
160. Yamamoto Y., Fujiuchi S., Hiramatsu M., Nishigaki Y., Takeda A., Fujita Y., Yamazaki Y., Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008 76 4 377 385 2-s2.0-56649098780 10.1159/000141866
161. Krapalis A. F., Reiter J., Machleidt F., Iwen K. A., Dodt C., Lehnert H., Sayk F., Ghrelin modulates baroreflex-regulation of sympathetic vasomotor tone in healthy humans. The American Journal of Physiology 2012 302 11 R1305 R1312 10.1152/ajpregu.00663.2011
162. Kishimoto I., Tokudome T., Hosoda H., Miyazato M., Kangawa K., Ghrelin and cardiovascular diseases. Journal of Cardiology 2012 59 1 8 13 2-s2.0-84855199907 10.1016/j.jjcc.2011.11.002
163. Harsch I. A., Konturek P. C., Koebnick C., Kuehnlein P. P., Fuchs F. S., Pour Schahin S., Wiest G. H., Hahn E. G., Lohmann T., Ficker J. H., Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. European Respiratory Journal 2003 22 2 251 257 2-s2.0-10744228002 10.1183/09031936.03.00010103 (Pubitemid 36986993)
164. Li A. M., Ng C., Ng S. K., Chan M. M. H., So H. K., Chan I., Lam C. W. K., Ng P. C., Wing Y. K., Adipokines in children with obstructive sleep apnea and the effects of treatment. Chest 2010 137 3 529 535 2-s2.0-77949525127 10.1378/chest.09-2153
165. Spruyt K., Capdevila O. S., Serpero L. D., Kheirandish-Gozal L., Gozal D., Dietary and physical activity patterns in children with obstructive sleep apnea. Journal of Pediatrics 2010 156 5 724.e3 730.e3 2-s2.0-77950520275 10.1016/j.jpeds.2009.11.010
166. Tsaoussoglou M., Bixler E. O., Calhoun S., Chrousos G. P., Sauder K., Vgontzas A. N., Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. Journal of Clinical Endocrinology and Metabolism 2010 95 1 143 150 2-s2.0-75149183118 10.1210/jc.2009-0435
167. Sánchez-De-La-Torre M., Barceló A., Piérola J., Esquinas C., de la Peña M., Durán-Cantolla J., Capote F., Masa J. F., Marin J. M., Vilá M., Cao G., Martinez M., de Lecea L., Gozal D., Montserrat J. M., Barbé F., Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. Respiratory Medicine 2011 105 12 1954 1960 2-s2.0-81155130881 10.1016/j.rmed.2011.08.014
168. Prugger C., Wellmann J., Heidrich J., Brand-Herrmann S., Keil U., Cardiovascular risk factors and mortality in patients with coronary heart disease. European Journal of Epidemiology 2008 23 11 731 737 2-s2.0-57649240491 10.1007/s10654-008-9291-x
169. Mondini S., Guilleminault C., Abnormal breathing patterns during sleep in diabetes. Annals of Neurology 1985 17 4 391 395 2-s2.0-0021880197 (Pubitemid 15079068)
170. Elmasry A., Lindberg E., Berne C., Janson C., Gislason T., Tageldin M. A., Boman G., Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. Journal of Internal Medicine 2001 249 2 153 161 2-s2.0-0035093964 10.1046/j.1365-2796.2001.00787.x (Pubitemid 32202505)
171. West S. D., Nicoll D. J., Stradling J. R., Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006 61 11 945 950 2-s2.0-33751203557 10.1136/thx.2005.057745 (Pubitemid 44787163)
172. Ficker J. H., Dertinger S. H., Siegfried W., König H. J., Pentz M., Sailer D., Katalinic A., Hahn E. G., Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. European Respiratory Journal 1998 11 1 14 19 2-s2.0-0031914619 10.1183/09031936.98.11010014 (Pubitemid 28081789)
173. Bottini P., Dottorini M. L., Cordoni M. C., Casucci G., Tantucci C., Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. European Respiratory Journal 2003 22 4 654 660 2-s2.0-0141928053 (Pubitemid 37258546)
174. Brown L. K., A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest 2002 122 3 774 778 2-s2.0-0036385780 10.1378/chest.122.3.774
175. Vgontzas A. N., Bixler E. O., Chrousos G. P., Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. Journal of Internal Medicine 2003 254 1 32 44 2-s2.0-0038009871 10.1046/j.1365-2796.2003.01177.x (Pubitemid 36819129)
176. Tassone F., Lanfranco F., Gianotti L., Pivetti S., Navone F., Rossetto R., Grottoli S., Gai V., Ghigo E., Maccario M., Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clinical Endocrinology 2003 59 3 374 379 2-s2.0-0042827423 10.1046/j.1365-2265. 2003.01859.x (Pubitemid 37046992)
177. Cheng N., Cai W., Jiang M., Wu S., Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatric Research 1997 41 6 852 856 2-s2.0-0030911016 (Pubitemid 27220575)
178. Li J., Bosch-Marce M., Nanayakkara A., Savransky V., Fried S. K., Semenza G. L., Polotsky V. Y., Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1 α Physiological Genomics 2006 25 3 450 457 2-s2.0-33646775277 10.1152/physiolgenomics.00293. 2005 (Pubitemid 43764766)
179. Polotsky V. Y., Li J., Punjabi N. M., Rubin A. E., Smith P. L., Schwartz A. R., O'Donnell C. P., Intermittent hypoxia increases insulin resistance in genetically obese mice. Journal of Physiology 2003 552 1 253 264 2-s2.0-0142062048 10.1113/jphysiol.2003.048173 (Pubitemid 37265483)
180. Braun B., Rock P. B., Zamudio S., Wolfel G. E., Mazzeo R. S., Muza S. R., Fulco C. S., Moore L. G., Butterfield G. E., Women at altitude: short-term exposure to hypoxia and/or α 1-adrenergic blockade reduces insulin sensitivity. Journal of Applied Physiology 2001 91 2 623 631 2-s2.0-0034912215 (Pubitemid 32681090)
181. Gasa M., Salord N., Fortuna A. M., Mayos M., Vilarrasa N., Dorca J., Montserrat J. M., Bonsignore M. R., Monasterio C., Obstructive sleep apnoea and metabolic impairment in severe obesity. European Respiratory Journal 2011 38 5 1089 1097 10.1183/09031936.00198810
182. McArdle N., Hillman D., Beilin L., Watts G., Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. The American Journal of Respiratory and Critical Care Medicine 2007 175 2 190 195 2-s2.0-33846265844 10.1164/rccm.200602-270OC (Pubitemid 46115091)
183. Resnick H. E., Jones K., Ruotolo G., Jain A. K., Henderson J., Lu W., Howard B. V., Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the strong heart study. Diabetes Care 2003 26 3 861 867 2-s2.0-0037882913 10.2337/diacare.26.3.861 (Pubitemid 36929356)
184. Piemonti L., Calori G., Mercalli A., Lattuada G., Monti P., Garancini M. P., Costantino F., Ruotolo G., Luzi L., Perseghin G., Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women impact on cardiovascular mortality. Diabetes Care 2003 26 10 2883 2889 2-s2.0-10744232583 10.2337/diacare.26.10.2883 (Pubitemid 37205563)
185. Hayashi M., Fujimoto K., Urushibata K., Takamizawa A., Kinoshita O., Kubo K., Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 2006 11 1 24 31 2-s2.0-33645107179 10.1111/j.1440-1843.2006.00780.x
186. Batsis J. A., Nieto-Martinez R. E., Lopez-Jimenez F., Metabolic syndrome: from global epidemiology to individualized medicine. Clinical Pharmacology and Therapeutics 2007 82 5 509 524 2-s2.0-35448950424 10.1038/sj.clpt.6100355 (Pubitemid 47622528)
187. Welborn T. A., Breckenridge A., Rubinstein A. H., Dollery C. T., Fraser T. R., Serum-insulin in essential hypertension and in peripheral vascular disease. The Lancet 1966 1 7451 1336 1337 2-s2.0-0014021322
188. Reaven G., Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002 106 3 286 288 2-s2.0-0037118703 10.1161/01.CIR.0000019884.36724.D9 (Pubitemid 34778947)
189. Grundy S. M., Brewer H. B. Jr., Cleeman J. I., Smith S. C. Jr., Lenfant C., Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 2 e13 e18
190. Ambrosetti M., Lucioni A. M., Conti S., Pedretti R. F., Neri M., Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk. Journal of Cardiovascular Medicine 2006 7 11 826 829 2-s2.0-33750366892 10.2459/01.JCM.0000250873.01649.41 (Pubitemid 44632197)
191. Basoglu O. K., Sarac F., Sarac S., Uluer H., Yilmaz C., Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Annals of Thoracic Medicine 2011 6 3 120 125 2-s2.0-80052905030 10.4103/1817-1737.82440
192. Vgontzas A. N., Bixler E. O., Chrousos G. P., Sleep apnea is a manifestation of the metabolic syndrome. Sleep Medicine Reviews 2005 9 3 211 224 2-s2.0-18844378616 10.1016/j.smrv.2005.01.006 (Pubitemid 40694188)
193. Gruber A., Horwood F., Sithole J., Ali N. J., Idris I., Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovascular Diabetology 2006 5 article 22 2-s2.0-33751253095 10.1186/1475-2840-5-22 (Pubitemid 44781864)
194. Lam J. C. M., Lam B., Lam C., Fong D., Wang J. K. L., Tse H., Lam K. S. L., Ip M. S. M., Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respiratory Medicine 2006 100 6 980 987 2-s2.0-33646037012 10.1016/j.rmed.2005.10.003
195. Shina K., Tomiyama H., Takata Y., Usui Y., Asano K., Hirayama Y., Nakamura T., Yamashina A., Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertension Research 2006 29 6 433 441 2-s2.0-33746298678 10.1291/hypres.29.433 (Pubitemid 44102811)
196. Bonsignore M. R., Esquinas C., Barcelo A., Sanchez-de-la-Torre M., Paternó A., Duran-Cantolla J., Marín J. M., Barbé F., Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. European Respiratory Journal 2012 39 5 1136 1143 2-s2.0-84860345856 10.1183/09031936.00151110
197. Bonsignore M. R., Zito A., Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Archives of Physiology and Biochemistry 2008 114 4 255 260 2-s2.0-54349109359 10.1080/13813450802307451
198. Lévy P., Pépin J., Arnaud C., Baguet J., Dematteis M., Mach F., Obstructive sleep apnea and atherosclerosis. Progress in Cardiovascular Diseases 2009 51 5 400 410 2-s2.0-60949108252 10.1016/j.pcad.2008.03.001
199. Su M. C., Chen Y. C., Huang K. T., Wang C. C., Lin M. C., Lin H. C., Association of metabolic factors with high-sensitivity C-reactive protein in patients with sleep-disordered breathing. European Archives of Oto-Rhino-Laryngology 2013 749 754
200. Sharma S. K., Agrawal S., Damodaran D., Sreenivas V., Kadhiravan T., Lakshmy R., Jagia P., Kumar A., CPAP for the metabolic syndrome in patients with obstructive sleep apnea. The New England Journal of Medicine 2011 365 24 2277 2286 2-s2.0-84855163177 10.1056/NEJMoa1103944
201. Agustí A. G., Systemic effects of chronic obstructive pulmonary disease. 2Proceedings of the American Thoracic Society 2005 2 4 367 370 10.1513/pats.200504-026SR (Pubitemid 41699698)
202. de Lucas-Ramos P., Izquierdo-Alonso J. L., Rodriguez-Gonzalez Moro J. M., Frances J. F., Lozano P. V., Bellon-Cano J. M., Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). International Journal of Chronic Obstructive Pulmonary Disease 2012 679 686
203. Maclay J. D., McAllister D. A., Johnston S., Raftis J., McGuinnes C., Deans A., Newby D. E., Mills N. L., MacNee W., Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011 66 9 769 774 2-s2.0-80051898444 10.1136/thx.2010.157529
204. Cella G., Sbarai A., Mazzaro G., Vanzo B., Romano S., Hoppensteadt D., Fareed J., Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clinical and Applied Thrombosis/Hemostasis 2001 7 3 205 208 2-s2.0-0034967158 (Pubitemid 32574181)
205. Moro L., Pedone C., Scarlata S., Malafarina V., Fimognari F., Antonelli-Incalzi R., Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 2008 59 3 357 364 2-s2.0-44849108219 10.1177/0003319707306141 (Pubitemid 351793158)
206. Nakanishi K., Takeda Y., Tetsumoto S., Iwasaki T., Tsujino K., Kuhara H., Jin Y., Nagatomo I., Kida H., Goya S., Kijima T., Maeda N., Funahashi T., Shimomura I., Tachibana I., Kawase I., Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. The American Journal of Respiratory and Critical Care Medicine 2011 183 9 1164 1175 2-s2.0-79955519064 10.1164/rccm.201007-1091OC
207. Minet C., Vivodtzev I., Tamisier R., Arbib F., Wuyam B., Timsit J. F., Monneret D., Borel J. C., Baguet J. P., Levy P., Pepin J. L., Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD. Respiratory Physiology and Neurobiology 2012 183 2 128 134 10.1016/j.resp.2012.06.017
208. Takabatake N., Nakamura H., Abe S., Inoue S., Hino T., Saito H., Yuki H., Kato S., Tomoike H., The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. The American Journal of Respiratory and Critical Care Medicine 2000 161 4 I 1179 1184 2-s2.0-0034109866 (Pubitemid 30243827)
209. Mills N. L., Miller J. J., Anand A., Robinson S. D., Frazer G. A., Anderson D., Breen L., Wilkinson I. B., McEniery C. M., Donaldson K., Newby D. E., MacNee W., Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008 63 4 306 311 2-s2.0-41849101460 10.1136/thx.2007.083493 (Pubitemid 351497941)
210. Andreas S., Anker S. D., Scanlon P. D., Somers V. K., Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005 128 5 3618 3624 2-s2.0-28144464489 10.1378/chest.128.5.3618 (Pubitemid 41698701)
211. Raupach T., Bahr F., Herrmann P., Luethje L., Heusser K., Hasenfuß G., Bernardi L., Andreas S., Slow breathing reduces sympathoexcitation in COPD. European Respiratory Journal 2008 32 2 387 392 2-s2.0-56149122019 10.1183/09031936.00109607
212. Heindl S., Lehnert M., Criée C., Hasenfuss G., Andreas S., Marked sympathetic activation in patients with chronic respiratory failure. The American Journal of Respiratory and Critical Care Medicine 2001 164 4 597 601 2-s2.0-0035880999 (Pubitemid 32801663)
213. Flenley D. C., Sleep in chronic obstructive lung disease. Clinics in Chest Medicine 1985 6 4 651 661 2-s2.0-0022355159 (Pubitemid 16175014)
214. Chaouat A., Weitzenblum E., Krieger J., Oswald M., Kessler R., Pulmonary hemodynamics in the obstructive sleep apnea syndrome results in 220 consecutive patients. Chest 1996 109 2 380 386 2-s2.0-0030024303
215. Hawrylkiewicz I., Sliwinski P., Gorecka D., Plywaczewski R., Zielinski J., Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Archives for Chest Disease 2004 61 148 152 (Pubitemid 40124040)
216. MacNee W., Maclay J., McAllister D., Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2008 5 8 824 833 2-s2.0-57349184081 10.1513/pats.200807-071TH
217. Gilmartin G. S., Tamisier R., Curley M., Weiss J. W., Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. The American Journal of Physiology 2008 295 2 H778 H785 2-s2.0-52449115677 10.1152/ajpheart.00653.2007
218. Shiina K., Tomiyama H., Takata Y., Yoshida M., Kato K., Nishihata Y., Matsumoto C., Odaira M., Saruhara H., Hashimura Y., Usui Y., Yamashina A., Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respiratory Medicine 2012 106 9 1335 1341 10.1016/j.rmed.2012.05.006
219. Marin J. M., Soriano J. B., Carrizo S. J., Boldova A., Celli B. R., Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. The American Journal of Respiratory and Critical Care Medicine 2010 182 3 325 331 2-s2.0-77956267083 10.1164/rccm.200912-1869OC
220. Pronzato C., Chronic obstructive pulmonary disease and obstructive sleep apnea. Association, consequences and treatment. Monaldi Archives for Chest Disease 2010 73 4 155 161 2-s2.0-79959296172
221. Nural S., Gunay E., Halici B., Celik S., Unlu M., Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 2013 36 1 66 74 10.1007/s10753-012-9520-z